Previous Article | Next Article 
Journal of Clinical Microbiology, January 2000, p. 375-381, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Pulmonary Infection Caused by Gymnascella
hyalinospora in a Patient with Acute Myelogenous
Leukemia
Peter C.
Iwen,1,*
Lynne
Sigler,2
Stefano
Tarantolo,3
Deanna A.
Sutton,4
Michael G.
Rinaldi,4,5
Rudy P.
Lackner,6
Dora I.
McCarthy,4 and
Steven H.
Hinrichs1
Department of Pathology and
Microbiology1 and Department of Internal
Medicine,3 University of Nebraska Medical
Center, Omaha, Nebraska; Microfungus Collection and Herbarium,
Devonian Botanic Garden, University of Alberta, Edmonton, Alberta,
Canada2; Fungus Testing Laboratory,
Department of Pathology, University of Texas Health Science Center at
San Antonio,4 and Audie L. Murphy
Division, South Texas Veterans Health Care
System,5 San Antonio, Texas; and
Department of Surgery, Long Island Jewish Medical Center, Long
Island, New York6
Received 28 June 1999/Returned for modification 18 August
1999/Accepted 29 September 1999
 |
ABSTRACT |
We report the first case of invasive pulmonary infection caused by
the thermotolerant ascomycetous fungus Gymnascella
hyalinospora in a 43-year-old female from the rural midwestern
United States. The patient was diagnosed with acute myelogenous
leukemia and treated with induction chemotherapy. She was discharged in
stable condition with an absolute neutrophil count of 100 cells per
µl. Four days after discharge, she presented to the Cancer Clinic with fever and pancytopenia. A solitary pulmonary nodule was found in
the right middle lobe which was resected by video-assisted thoracoscopy
(VATHS). Histopathological examination revealed septate branching
hyphae, suggesting a diagnosis of invasive aspergillosis; however,
occasional yeast-like cells were also present. The culture grew a mold
that appeared dull white with a slight brownish tint that failed to
sporulate on standard media. The mold was found to be positive by the
AccuProbe Blastomyces dermatitidis Culture ID Test
(Gen-Probe Inc., San Diego, Calif.), but this result appeared to be
incompatible with the morphology of the structures in tissue. The
patient was removed from consideration for stem cell transplant and was
treated for 6 weeks with amphotericin B (AmB), followed by itraconazole
(Itr). A VATHS with biopsy performed 6 months later showed no evidence
of mold infection. In vitro, the isolate appeared to be susceptible to
AmB and resistant to fluconazole and 5-fluorocytosine. Results for Itr
could not be obtained for the case isolate due to its failure to grow
in polyethylene glycol used to solubilize the drug; however, MICs for a
second isolate appeared to be elevated. The case isolate was
subsequently identified as G. hyalinospora based on its
formation of oblate, smooth-walled ascospores within yellow or
yellow-green tufts of aerial hyphae on sporulation media. Repeat
testing with the Blastomyces probe demonstrated
false-positive results with the case isolate and a reference isolate of
G. hyalinospora. This case demonstrates that both
histopathologic and cultural features should be considered for the
proper interpretation of this molecular test and extends the list of
fungi recognized as a cause of human mycosis in immunocompromised patients.
 |
INTRODUCTION |
Invasive mold infections have
emerged as major causes of morbidity and mortality in immunocompromised
patients, including patients with hematological malignancies undergoing
treatment (7, 23, 37). Aspergillus species are
the most common cause of invasive mold infection, but other
opportunistic molds such as Fusarium species,
Pseudallescheria boydii, and Rhizopus species have frequently been reported as causes of invasive disease (1, 3,
4, 13, 16, 20). The number of mold species causing invasive
infection continues to expand, with the addition of fungi once thought
incapable of causing human disease (12, 14, 18, 19, 26).
This report describes the first case of an invasive pulmonary mycosis
caused by the thermotolerant ascomycete Gymnascella hyalinospora in a patient undergoing therapy for acute myelogenous leukemia.
(Presented in part at the 99th General Meeting of the American Society
for Microbiology, Chicago, Ill., May 1999.)
 |
CASE REPORT |
A 43-year-old female childcare employee presented with a 3-month
history of sinusitis. A complete blood count showed pancytopenia plus
circulating blasts and a diagnosis of acute myelogenous leukemia (FAB-M1) was made. Induction chemotherapy, consisting of idarubicin and
cytarabine, was administered, and the patient was discharged in stable
condition 8 days following chemotherapy with no evidence of cancer. At
discharge, an absolute neutrophil count of <100 cells per µl was
noted. Four days after discharge, she presented to the Cancer Clinic
with fever and pancytopenia. A chest radiograph at that time showed a
2.5-cm right-middle-lobe opacity. A computerized tomography (CT) scan
of the thorax demonstrated a 2.5-by-1.8-cm pleural-based peripheral
nodule. A wedge resection of the right upper lobe, along with a biopsy
of the parietal pleura, was accomplished with video-assisted
thoracostomy (VATHS). Histopathology of the lung and pleural tissues
revealed hemorrhagic infarcts and numerous septate hyphae with
Aspergillus-like characteristics (Fig.
1). Also present were numerous solitary
yeast-like cells, some of which appeared to be budding (Fig.
2).

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 1.
Methenamine silver stain of lung tissue. (A) Hyphal
elements and small, oval ascospores that resemble yeast cells can be
seen. Magnification, ×580. (B) Higher-magnification view of solitary
ascospores (arrow). Magnification, ×1,120.
|
|

View larger version (121K):
[in this window]
[in a new window]
|
FIG. 2.
Methenamine silver stain of lung tissue showing what
appears to be germinating ascospores that resemble budding yeast cells.
Magnification, ×400.
|
|
Tissue from the right upper lobe was plated on Sabouraud dextrose agar
with chloramphenicol (SAB-C; Remel, Lenexa, Kans.) and incubated at
30°C. Bacterial cultures were also performed on this tissue by using
sheep blood agar, chocolate agar, MacConkey agar, and thioglycolate
broth (all from Remel). On SAB-C, a rapidly growing mold with a white
colony grew which subsequently became gray (Fig.
3A, left). The same white mold grew on
all bacterial media except MacConkey agar. A 10-day-old slide culture
prepared on plain SAB (Remel) incubated at 30°C revealed septate
hyphae but no reproductive structures. The mold was positive by the
AccuProbe Blastomyces dermatitidis Culture ID Test. In
consideration of possible Aspergillus or
Blastomyces infection, the patient was removed as a
candidate for stem cell transplantation. A serum sample, submitted to a
reference laboratory for serological studies, was subsequently reported
as negative for antibodies to Aspergillus and
Blastomyces as determined by immunodiffusion testing.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 3.
G. hyalinospora case isolate (UAMH 9359) on
SAB-C (left) and Czapek agar (right) at 21 days at 30°C (A), on PDA
showing the confluent yellow-white mycelium after 4 weeks at 30°C
(B), and on PFA showing sectors of different colonial color and texture
at 21 days at 30°C (C).
|
|
Based on a diagnosis of fungal pneumonia, intravenous amphotericin B
(AmB) was started at a dose of 1 mg/kg of body weight/day. At 8 days
after the operation, the patient was discharged and continued to
receive AmB for a 6-week period. Therapy with itraconazole (Itr) was
administered orally initially at a dose of 200 mg daily and then
increased to 400 mg for an additional 6 weeks because of low serum
levels. At the completion of AmB treatment, a CT scan of the thorax was
performed which demonstrated scar tissue in the right upper lobe of the
lung. A repeat VATHS was performed 112 days following the completion of
AmB therapy, with biopsy of the pleura and resection of the lung scar
to verify that the mold infection had resolved prior to any
consolidation chemotherapy. There was no evidence of fungal elements by
histopathology of this tissue, and no growth was obtained by culture.
The patient subsequently relapsed at approximately 9 months after
induction chemotherapy and was reinduced with idarubicin and
cytarabine. A second remission was achieved and, although the patient
developed prolonged neutropenic fever and was treated with AmB, there
was no evidence of invasive fungal infection noted. The patient was
subsequently placed on a protocol for stem cell transplantation.
 |
MATERIALS AND METHODS |
Mycology.
The lung isolate was forwarded to the Fungus
Testing Laboratory, Department of Pathology, University of Texas Health
Science Center (UTHSC) at San Antonio, Tex., for characterization and susceptibility testing. It was entered into the UTHSC stock collection under accession number UTHSC 98-1356. Due to the absence of
sporulation, the isolate was subsequently referred for additional
testing to the University of Alberta Microfungus Collection and
Herbarium (UAMH), where it was deposited as strain UAMH 9359. To induce sporulation, the isolate was subcultured onto a variety of media, including potato dextrose agar (PDA; Difco Laboratories, Detroit, Mich.), potato flakes agar (PFA), Czapek agar, cereal agar, and oatmeal
salts agar (OAT), the latter prepared in-house (15). The
case isolate was identified by its micromorphological features and
confirmed by morphological and molecular comparison with a reference
isolate from a human source (strain UAMH 7366, repeatedly isolated from
the respiratory tract of an immunosuppressed patient, deposited by I. Weitzman, New York, N.Y.). Colonial features were examined on PDA and
OAT with growth rates evaluated at 25, 30, and 37°C. The microscopic
morphology was examined from colonies on OAT or Czapek agar or from
slide culture mounts by using cereal agar. A subculture of the case
isolate was deposited in the American Type Culture Collection under
accession number ATCC 204275.
Antifungal susceptibility testing.
Susceptibility testing
was performed on both the case isolate and UAMH 7366, utilizing the
National Committee for Clinical Laboratory Standards macrobroth
dilution method M27-A, modified for mold testing (21).
Briefly, the isolates and the Paecilomyces control strain
(UTHSC 90-459) were grown on PFA for 7 days at 25°C, and the inocula
were standardized spectrophotometrically. The PFA slants were overlaid
with sterile distilled water, and suspensions were made by gently
scraping the colonies with the tip of a Pasteur pipette. Heavy hyphal
fragments were allowed to settle, and the upper, homogenous suspensions
were removed. Suspensions were adjusted to a 95% transmission at 530 nm and then diluted 1:10 in medium to provide a 1.0 × 104 final inoculum concentration as determined by plate
counts. Final drug concentration ranges were as follows: for AmB (E.R.
Squibb & Sons, Princeton, N.J.), 0.03 to 16 µg per ml; for
5-fluorocytosine (5-Fc; Roche Laboratories, Nutley, N.J.), 0.125 to 64 µg per ml; for fluconazole (Flu; Pfizer, Inc., New York, N.Y.), 0.125 to 64 µg per ml; for Itr (Janssen Pharmaceutica, Titusville, N.J.), 0.015 to 8 µg per ml; and for ketoconazole (Ket; Janssen
Pharmaceutica, Titusville, N.J.), 0.03 to 16 µg per ml. AmB was
tested in Antibiotic Medium 3 (Difco, Detroit, Mich.); other antifungal
agents were tested in RPMI 1640 with L-glutamine and
morpholinepropanesulfonic acid (MOPS) buffer at a concentration of 165 mM and without sodium bicarbonate (American Biorganics, Inc., Niagara
Falls, N.Y.). Previously prepared, frozen drug tubes containing 0.1 ml
of drug were allowed to thaw and were inoculated with 0.9 ml of the
hyphal medium suspension. The tubes were incubated at 35°C, and MICs were read at the first 24-hr interval when growth was observed in the
drug-free growth control. MICs were defined as the drug concentration
of the first tube that yielded a score of 0 (optically clear) for AmB
and a score of 2 (reduction in turbidity of
80% in contrast to the
drug-free control tube) for 5-Fc, Flu, Itr, and Ket. Minimum lethal
concentrations (MLCs) for AmB were determined by plating 100-µl
samples onto SBA plates from tubes containing the following: drug-free
control, AmB at the MIC, and AmB at concentrations above the MIC. All
plates were incubated at 35°C. The MLC was defined as the lowest
concentration of antifungal compound resulting in five or fewer
colonies on the SBA plate, which represented 99.9% killing
(27).
Molecular testing.
The commercially available DNA probe for
identification of Blastomyces dermatitidis (AccuProbe;
Gen-Probe, Inc., San Diego, Calif.) was used per the manufacturer's
instructions. A signal greater than or equal to 50,000 relative light
units (RLU) was considered positive. The test was performed three times
on the case isolate and once on the reference strain, UAMH 7366. Each isolate was also tested once with the probe for Histoplasma
capsulatum. Comparison of the ribosomal DNA (rDNA) internal
transcribed spacer regions (ITS1 and ITS2) was used to confirm identity
between the case isolate and the reference strain (P. C. Iwen,
T. J. Henry, S. R. Tarantolo, and S. H. Hinrichs, Abstr.
Focus Fungal Infect. No. 9, abstr. 26, 1999).
 |
RESULTS |
The case isolate (UAMH 9359) was identified as G. hyalinspora (Kuehn, G.F. Orr & G.R. Ghosh) Currah by its colonial
and macroscopic characteristics, as well as micromorphological
features. Colonies on PDA at 30°C were initially flat, with a
glabrous (smooth) yellow-gray surface mycelium overlaid with sparse
tufts of cottony-white aerial hyphae and an orange-brown reverse. A tan
pigment diffused into the agar. After 4 weeks, the colony developed
raised and more confluent yellow-white woolly mycelium, and this
mycelium darkened to pale yellow or olive green after 10 weeks (Fig.
3B). On oatmeal agar at 30°C after 14 days, the colony was 100 mm in
diameter, flat, thinly cottony, and yellow-white in the center; after
10 weeks, the center became golden yellow with a few tufts of green mycelium, while the margin was thin and white. The case isolate and
reference isolate (UAMH 7366) demonstrated similar growth rates at 30 and 37°C, attaining colony diameters of 65 to 75 mm on PDA after 14 days. Both isolates grew slower at 25°C (colony diameters of 35 mm
for the case isolate and of 55 mm for UAMH 7366 in 14 days on PDA).
Colonies of the reference strain were more velvety and bright colored,
becoming golden yellow to deep green on PDA and gray to deep green on
oatmeal agar after 10 weeks. The case isolate differed from UAMH 7366 in its tendency to develop sectors of different color or texture on all
media (Fig. 3C), but sectoring is common among isolates of G. hyalinospora (5). Changes in colony color from white to
yellow or green occurred with the commencement of ascosporulation and
the maturation of ascospores (sexual spores or meiospores) that formed
within loosely aggregated naked clusters. In age, the ascospore masses
were associated with loosely arranged, thicker-walled yellow hyphae,
which were especially prominent on Czapek agar (Fig. 3A, right). The
vegetative hyphae were narrow, commonly measuring 2 to 3 µm wide and
sometimes showing swellings up to 4 or 5 µm wide at one end of a cell
(racket hyphae). Asci measured 8 to 11 µm long by 5.5 to 8.5 µm
wide. Ascospores were 2.8 to 3.2 µm long and 2.2 to 2.5 µm wide,
oblate (spherical in the face view and flattened in the side view), and pale yellow en masse. They appeared smooth under light microscopy (Fig.
4), but by scanning electron microscopy
they appeared to be covered with a warty membrane that sloughed off
(Fig. 5). In addition to their
morphological similarities, the case and reference isolates
demonstrated >99% homology between the ITS region sequences.

View larger version (90K):
[in this window]
[in a new window]
|
FIG. 4.
Development of asci and ascospores in G. hyalinospora. (A) Solitary asci (curved arrow) and asci in
clusters (large arrow). Racquet hyphae also may be seen (small arrow).
Magnification, ×460. (B) Solitary ascus and single ascospore in side
view. Magnification, ×1,120. (C) Mature oblate ascospores associated
with thick-walled hyphae. The arrow points to two ascospores in
different orientations, showing that they appear round in the face view
and slightly flattened in the side view. Magnification, ×1,120.
|
|

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 5.
Ascospores examined by scanning electron microscopy. (A)
Ascospores released from the ascus in the case isolate. Ascospores in
one group appear to be covered with a warty membrane covering
(perispore). Bar, 5 µm. (B) Ascospore shedding the outer membrane in
the case isolate. Bar, 2.5 µm. (C) Ascospores of the reference
isolate showing features identical to those of the case isolate. Bar, 6 µm.
|
|
The case isolate was tested with the DNA probe for B. dermatitidis because it appeared to be unusual at initial
presentation, having sterile glabrous colonies with a slight brownish
tint as is occasionally seen with atypical isolates of B. dermatitidis. Although the test was done to rule out B. dermatitidis, two tests performed 15 days apart gave positive
results, with RLU readings of 85,686 and 111,548. Additionally, the
probe test was positive for the UAMH reference isolate of G. hyalinospora (246,835 RLU). However, a third test done on the case
isolate approximately 5 months later recorded a negative result, with
an RLU reading of 40,065. Neither isolate demonstrated a positive
reaction when tested with the AccuProbe assay for H. capsulatum.
The drug susceptibility data for the case isolate and UAMH 7366 indicated that both isolates have a similar pattern of susceptibility (Table 1). Based upon serum drug
concentrations achievable by standard dosing regimens, the isolates
appeared to be susceptible to AmB, both by MICs and MLCs. In vitro data
for Ket and Itr differed for the two isolates. The case isolate
demonstrated an MIC of 2 µg/ml for Ket but failed to grow in the
polyethylene glycol used to stabilize Itr for drug dilutions, and thus
results were not obtained. The 48-h MICs of 4 µg/ml for Ket and
Itr from the UAMH 7366 isolate appeared elevated. Both isolates showed
resistance to 5-Fc and Flu.
 |
DISCUSSION |
G. hyalinospora is a member of the ascomycetes order
Onygenales, family Gymnoascaceae. Most human
pathogenic members of the order are placed in the classifications
Arthrodermataceae (dermatophytes) and
Onygenaceae (systemic dimorphic pathogens and some
other species) (2, 15, 30). Currah (5)
redescribed the genus Gymnascella and included a number of
species that had formerly been included in the genera
Arachniotus, Rollandina, and
Gymnoascus. The genus is distinguished by asci and
ascospores that are naked or surrounded by scarcely differentiated
hyphae and ascospores that are smooth to irregularly lumpy and oblate
(5, 15). Gymnascella dankaliensis has been
reported as a rare agent of onychomycosis (15, 35). Other
members of the genus have not been confirmed as pathogens of humans or
other animals, even though they are occasionally isolated from
associated materials (dung, litter, and soil associated with animals)
or from the animals themselves (lung, skin scrapings, hair, etc.)
(5, 32). Based on prior records of its isolation and its
ability to grow well at 37°C, G. hyalinospora has been considered a possible cause of infection. Strain UAMH 7366 was isolated
from tracheal aspirate, bronchial washings, and sputum from an
immunosuppressed patient; however, histopathological documentation of
invasive disease could not be obtained (32). The present study demonstrates the pathogenic potential of this ascomycete species
in a patient with acute myelogenous leukemia undergoing chemotherapy.
The absence of sporulation on standard media may present difficulties
in identifying an isolate of G. hyalinospora in the clinical
setting. However, ascosporulation is induced on sporulation media such
as OAT within 2 to 4 weeks at 30 or 37°C, and the smooth, oblate
ascospores develop within yellow to yellow-green sectors or patches.
Although the case isolate was identified by micromorphological features, analysis of sequences from the rDNA internal transcribed spacer regions ITS1 and ITS2 provided another method to confirm the
identity with the reference isolate and to further investigate the
potential of this technique to classify difficult-to-identify clinical
isolates (Iwen et al., Abstr. Focus Fungal Infect.).
Our patient's infection was not evident upon discharge from the
hospital following induction chemotherapy, but it appeared radiologically in the lung 4 days after discharge. It is not known where the patient acquired the infection, but it is suspected that she
may have inhaled ascospores prior to admission and that her induced
immunosuppression allowed in situ germination to the hyphal form (Fig.
2). The histopathologic findings are consistent with this hypothesis.
Although the individual cells observed in the tissue section were
initially thought to be yeast-like, retrospective reexamination
revealed that the cells were similar in size (3 µm long by 2 to 2.5 µm wide) and shape to ascospores formed in culture, although they
were not quite as regular in shape (Fig. 4). G. hyalinospora
has been isolated from agricultural soils and once from a lesion on the
comb of a rooster in India (UAMH 6510). Our patient came from a rural
background and had resided in the country, where she raised chickens,
geese, and guinea hens. Attempts to isolate the organism from the soil
where the fowl had resided failed because of other saprophytic fungal overgrowth.
AmB remains the treatment of choice for prophylaxis and treatment of
invasive mold infections, even though Itr has been shown to be
effective in the treatment of some cases (6, 8, 9, 10, 29,
36). It had been shown previously that leukemia and solid organ
transplant patients who develop a solitary pulmonary nodule benefit
from aggressive surgical resection of the nodule with improved survival
(25, 28). In our patient's case, the lesion was surgically
removed prior to the administration of an antifungal, so the efficacy
of the antifungals is difficult to evaluate. Susceptibility data (Table
1) suggested that the organism was susceptible to AmB. Our patient was
treated also with Itr, but susceptibility of the isolate to this drug
could not be determined due to its failure to grow in the drug dilution
tubes; the MIC for the reference strain appeared to be elevated. The
role of antifungal therapy in the overall clinical response of this
patient is unclear since surgery was a critical part of this patient's management. A second VATHS with biopsy was performed 112 days following
the completion of AmB therapy after the Itr had been started. The
tissue culture from this sample was negative for fungus; however, this
may have been compromised because of antifungal therapy, although no
histological evidence of fungus was observed.
Two unusual findings made diagnosis in this case difficult. The first
was the histopathological appearance of the fungus. The hyphae
resembled those of Aspergillus species, leading to an
initial diagnosis of suspected invasive aspergillosis, but the presence
of small oval yeast-like cells were inconsistent with this diagnosis.
Since Aspergillus species are vasculopathic and their
presence may imply a grave disease process, there was an urgent need
for an accurate diagnosis (6), but diagnosis was impeded by
the difficulty in interpreting the histopathology and by the initial
failure of the isolate to sporulate. Because some aspects of the
cultural features suggested that it might be an atypical isolate, the
DNA probe for B. dermatitidis was performed to rule out this
species. The second unusual finding was the positive probe result for
B. dermatitidis. Once the isolate produced ascospores and
was identified as G. hyalinospora it was retested, and
positive results were obtained with both the case and the reference
isolates. Care was taken to ensure that the product had not exceeded
its expiration date and that the manufacturer's instructions were
followed. Although tests were twice positive for the case isolate, a
third test done approximately 5 months after the original two tests
recorded a negative result, with an RLU reading of 40,065. It is
unknown why the B. dermatitidis probe hybridized the rDNA
released from this species. Although false-positive results have
occurred with Paracoccidioides brasiliensis (21),
these taxa are close relatives (11, 24). In contrast, current taxonomic concepts place G. hyalinospora and
B. dermatitidis in different families (5). In
their phylogeny of the Onygenales, Leclerc et al. found that
two members of the Gymnoascaceae clustered with some members
of the Onygenaceae and apart from a group including the
dimorphic pathogens (17).
While the gene probes have been reported to be highly specific
(22, 34), the probe was not reliable in confirming the identity of the isolate in this case. The presence of hyphae in tissue,
together with the absence of structures that are characteristic of
B. dermatitidis, suggested to us that the probe results were misleading. B. dermatitidis produces a yeast phase
characterized by large (8 to 10 µm in diameter), thick-walled,
broad-based budding cells and in culture forms solitary conidia borne
on stalks (15, 31). Sterile isolates are rarely encountered
that would be difficult to distinguish from G. hyalinospora,
but ascosporulation can be induced in the latter by the use of
appropriate media. Our results show that it is wise to follow the
manufacturer's direction, which states that "results from the
[Blastomyces Culture Identification Test] should be
interpreted in conjunction with the laboratory and clinical data."
This case further illustrates that septate branching hyphae identified
in tissue should not be immediately interpreted as
Aspergillus species and that a combination of tests is
needed to make an accurate diagnosis.
This study adds the ascomycete G. hyalinospora to the list
of opportunistic human pathogens. As immunosuppressive therapies become
more widely used, environmental fungi with low pathogenicity will
continue to emerge as causes of invasive disease, and it is important
that the pathogen be recognized in a timely manner for effective
management of the patient.
 |
ACKNOWLEDGMENTS |
We thank Mary Parsons and Delinda Sundsboe of the Clinical
Microbiology Laboratory, Mycology Section, at the Nebraska Health System, and Arlene Flis, Linda Abbott, and Ming Chen at the University of Alberta, for their assistance.
L.S. acknowledges financial assistance from the Natural Sciences and
Engineering Research Council of Canada.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology and Microbiology, University of Nebraska Medical Center,
986495 Nebraska Medical Center, Omaha, NE 68198-6495. Phone: (402)
559-7774. Fax: (402) 559-4077. E-mail: piwen{at}unmc.edu.
 |
REFERENCES |
| 1.
|
Boutati, E. I., and E. J. Anaissie.
1997.
Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.
Blood
90:999-1008[Abstract/Free Full Text].
|
| 2.
|
Bowman, B. H., and J. W. Taylor.
1993.
Molecular phylogeny of pathogenic and non-pathogenic Onygenales, p. 168-178.
In
D. R. Reynolds, and J. W. Taylor (ed.), The fungal holomorph: a consideration of mitotic, meiotic and pleomorphic speciation. CAB International, Wallingford, United Kingdom.
|
| 3.
|
Breton, P.,
P. Germaud,
O. Morin,
A. F. Audouin,
N. Milpied, and J. L. Harousseau.
1998.
Rare pulmonary mycoses in patients with hematologic diseases.
Rev. Pneumol. Clin.
54:253-257[Medline].
|
| 4.
|
Cunningham, R., and D. C. Mitchell.
1996.
Amphotericin B responsive Scedosporium apiospermum infection in a patient with acute myeloid leukaemia.
J. Clin. Pathol.
49:93-94[Abstract/Free Full Text].
|
| 5.
|
Currah, R. S.
1985.
Taxonomy of the Onygenales: Arthrodermataceae, Gymnoascaceae, Myxotrichaceae, and Onygenaceae.
Mycotaxon
24:1-216.
|
| 6.
|
Denning, D. W.
1996.
Diagnosis and management of invasive aspergillosis.
Curr. Clin. Top. Infect. Dis.
16:277-299[Medline].
|
| 7.
|
Denning, D. W.
1998.
Invasive aspergillosis.
Clin. Infect. Dis.
26:781-803[Medline].
|
| 8.
|
Denning, D. W.
1996.
Therapeutic outcome in invasive aspergillosis.
Clin. Infect. Dis.
23:608-615[Medline].
|
| 9.
|
Denning, D. W.,
A. Marinus,
J. Cohen,
D. Spence,
R. Herbrecht,
L. Pagano,
C. Kibbler,
V. Kermery,
F. Offner,
C. Cordonnier,
U. Jehn,
M. Ellis,
L. Collette, and R. Sylvester.
1998.
An EORTC multicenter prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome.
EORTC Invasive Fungal Infections Cooperative Group. J. Infect.
37:173-180.
|
| 10.
|
Graybill, J. R.
1998.
Itraconazole: managing mycotic complications in immunocompromised patients.
Semin. Oncol.
25(Suppl. 7):58-63[Medline].
|
| 11.
|
Gueho, E.,
M. C. Leclerc,
G. S. Hoog, and B. Dupont.
1997.
Molecular taxonomy and epidemiology of Blastomyces and Histoplasma species.
Mycoses
40:69-81[Medline].
|
| 12.
|
Iwen, P. C.,
M. E. Rupp,
M. R. Bishop,
M. G. Rinaldi,
D. A. Sutton,
S. Tarantolo, and S. H. Hinrichs.
1998.
Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation.
J. Clin. Microbiol.
36:3713-3717[Abstract/Free Full Text].
|
| 13.
|
Iwen, P. C.,
M. E. Rupp,
A. N. Langnas,
E. C. Reed, and S. H. Hinrichs.
1998.
Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature.
Clin. Infect. Dis.
26:1092-1097[Medline].
|
| 14.
|
James, E. A.,
K. Orchard,
P. H. W. McWhinney,
D. W. Warnock,
E. M. Johnson,
A. B. Mehta, and C. C. Kibbler.
1997.
Disseminated infection due to Cylindrocarpon lichenicola in a patient with acute myeloid leukaemia.
J. Infect.
34:65-67[CrossRef][Medline].
|
| 15.
|
Kane, J.,
R. C. Summerbell,
L. Sigler,
S. Krajden, and G. Land.
1997.
Laboratory handbook of dermatophytes. A clinical guide and laboratory manual of dermatophytes and other filamentous fungi from skin, hair and nails.
Star Publishing Co., Belmont, Calif.
|
| 16.
|
Kumar, R. R.,
B. R. Kumar,
M. Shafiulla,
K. C. Lakshmaiah, and H. Sridhar.
1997.
Fusarium solani infection in a patient with acute myelogenous leukemia: a case report.
Indian J. Pathol. Microbiol.
40:555-557[Medline].
|
| 17.
|
Leclerc, M. C.,
H. Philippe, and E. Gueho.
1994.
Phylogeny of dermatophytes and dimorphic fungi based on large subunit ribosomal RNA sequence comparison.
J. Med. Vet. Mycol.
32:331-341[Medline].
|
| 18.
|
Lonial, S.,
L. Williams,
G. Carrum,
M. Ostrowski, and P. McCarthy, Jr.
1997.
Neosartorya fischeri: an invasive fungal pathogen in an allogeneic bone marrow transplant patient.
Bone Marrow Transplant.
19:753-755[CrossRef][Medline].
|
| 19.
|
Lundstrom, T. S.,
M. R. Fairfax,
M. C. Dugan,
J. A. Vazquez,
P. H. Chadrasekar,
E. Abella, and C. Kasten-Sportes.
1997.
Phialophora verrucosa infection in a BMT patient.
Bone Marrow Transplant.
20:789-791[CrossRef][Medline].
|
| 20.
|
Mangini, C., and B. de Camargo.
1999.
Fungal infection due to Fusarium spp. in children with refractory hematologic malignancies.
Med. Ped. Oncol.
32:149-150[CrossRef][Medline].
|
| 21.
|
National Committee for Clinical Laboratory Standards.
1997.
Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 22.
|
Padhye, A. A.,
G. Smith,
P. G. Standard,
D. McLaughlin, and L. Kaufman.
1994.
Comparative evaluation of chemiluminescent DNA probe assays and exoantigen tests for rapid identification of Blastomyces dermatitidis and Coccidioides immitis.
J. Clin. Microbiol.
32:867-870[Abstract/Free Full Text].
|
| 23.
|
Perfect, J. R., and W. A. Schell.
1996.
The new fungal opportunists are coming.
Clin. Infect. Dis.
22:S112-S118.
|
| 24.
|
Peterson, S. W., and L. Sigler.
1998.
Molecular genetic variation in Emmonsia crescens and E. parva, etiologic agents of adiaspiromycosis, and their phylogenetic relationship to Blastomyces dermatitidis (Ajellomyces dermatitidis) and other systemic fungal pathogens.
J. Clin. Microbiol.
36:2918-2925[Abstract/Free Full Text].
|
| 25.
|
Reichenberger, F.,
J. Habicht,
A. Kaim,
P. Dalquen,
F. Bernet,
R. Schlapfer,
P. Stulz,
A. P. Perruchoud,
A. Tichelli,
A. Gratwohl, and M. Tamm.
1998.
Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases.
Am. J. Respir. Crit. Care Med.
158:885-890[Abstract/Free Full Text].
|
| 26.
|
Richter, S.,
M. G. Cormican,
M. A. Pfaller,
C. K. Lee,
R. Gingrich,
M. G. Rinaldi, and D. A. Sutton.
1999.
Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature.
J. Clin. Microbiol.
37:1154-1160[Abstract/Free Full Text].
|
| 27.
|
Rinaldi, M. G., and A. W. Howell.
1988.
Antifungal antimicrobics: laboratory evaluation, p. 325-356.
In
B. Wentworth (ed.), Diagnostic procedures for mycotic and parasitic infections, 7th ed. American Public Health Association, Washington, D.C.
|
| 28.
|
Salerno, C. T.,
D. W. Ouyang,
T. S. Pederson,
D. M. Larson,
J. P. Shake,
E. M. Johnson, and M. A. Maddaus.
1998.
Surgical therapy for pulmonary aspergillosis in immunocompromised patients.
Ann. Thorac. Surg.
65:1415-1419[Abstract/Free Full Text].
|
| 29.
|
Sheehan, D. J.,
C. A. Hitchcock, and C. M. Sibley.
1999.
Current and emerging azole antifungal agents.
Clin. Microbiol. Rev.
12:40-79[Abstract/Free Full Text].
|
| 30.
|
Sigler, L.
1993.
Perspectives on Onygenales and their anamorphs by a traditional taxonomist, p. 161-168.
In
D. R. Reynolds, and J. W. Taylor (ed.), The fungal holomorph: a consideration of mitotic, meiotic and pleomorphic speciation. CAB International, Wallingford, United Kingdom.
|
| 31.
|
Sigler, L.
1996.
Ajellomyces crescens sp. nov., taxonomy of Emmonsia species and relatedness with Blastomyces dermatitidis (teleomorph Ajellomyces dermatitidis).
J. Med. Vet. Mycol.
34:303-314[Medline].
|
| 32.
|
Sigler, L., and A. Flis.
1998.
Catalogue of the University of Alberta Microfungus Collection and Herbarium, 3rd ed., p. 213.
University of Alberta, Edmonton, Alberta, Canada.
|
| 33.
|
Sigler, L.,
S. P. Abbott, and A. J. Woodgyer.
1994.
New records of nail and skin infection due to Onychocola canadensis and description of its teleomorph Arachnomyces nodosetosus sp. nov.
J. Med. Vet. Mycol.
32:275-285[Medline].
|
| 34.
|
Stockman, L.,
K. A. Clark,
J. M. Hunt, and G. D. Roberts.
1993.
Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum.
J. Clin. Microbiol.
31:845-850[Abstract/Free Full Text].
|
| 35.
|
Summerbell, R. C.,
J. Kane, and S. Krajden.
1989.
Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi.
Mycoses
32:609-619[Medline].
|
| 36.
|
Walsh, T. J.,
R. W. Finberg,
C. Arndt,
J. Hiemenz,
C. Schwartz,
D. Bodensteiner,
P. Pappas,
N. Seibel,
R. N. Greenberg,
S. Dummer,
M. Schuster, and J. S. Holcenberg.
1999.
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia.
N. Engl. J. Med.
340:764-771[Abstract/Free Full Text].
|
| 37.
|
White, D. A., and J. T. Santamauro.
1995.
Pulmonary infections in immunosuppressed patients.
Curr. Opin. Pulmon. Med.
1:202-208[Medline].
|
Journal of Clinical Microbiology, January 2000, p. 375-381, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pounder, J. I., Hansen, D., Woods, G. L.
(2006). Identification of Histoplasma capsulatum, Blastomyces dermatitidis, and Coccidioides Species by Repetitive-Sequence-Based PCR.. J. Clin. Microbiol.
44: 2977-2982
[Abstract]
[Full Text]
-
Brandt, M. E., Gaunt, D., Iqbal, N., McClinton, S., Hambleton, S., Sigler, L.
(2005). False-Positive Histoplasma capsulatum Gen-Probe Chemiluminescent Test Result Caused by a Chrysosporium Species. J. Clin. Microbiol.
43: 1456-1458
[Abstract]
[Full Text]
-
Al-Mohsen, I. Z., Sutton, D. A., Sigler, L., Almodovar, E., Mahgoub, N., Frayha, H., Al-Hajjar, S., Rinaldi, M. G., Walsh, T. J.
(2000). Acrophialophora fusispora Brain Abscess in a Child with Acute Lymphoblastic Leukemia: Review of Cases and Taxonomy. J. Clin. Microbiol.
38: 4569-4576
[Abstract]
[Full Text]